WHO/BS/2017.2324 Proposed WHO Reference Reagent for Activated Blood Coagulation Factor X(FXa), Human

Overview

Approval was obtained from the Expert Committee on Biological Standardization of WHO to prepare a WHO Reference Reagent (RR) for Activated Blood Coagulation Factor X (FXa), Human. The RR is proposed as a replacement for the current Non-WHO Reference Material for FXa (75/595), of bovine origin. A candidate material was donated by a manufacturer and was formulated, lyophilized and coded 15/102. The proposed WHO RR was calibrated against 75/595 using a direct chromogenic assay with a potency estimate for 15/102 based on results from 12 independent assays from two laboratories. Intra-laboratory variability was low (GCV<4%) and laboratory GM estimates showed good agreement (6.5 and 6.8 units per ampoule). The overall geometric mean was used to potency assign the candidate RR (15/102), which was determined to be 6.7 units per ampoule.

 

WHO Team
Health Product Policy and Standards (HPS), Norms and Standards for Biological Products (NSB), Technical Standards and Specifications (TSS)
Number of pages
10
Reference numbers
WHO Reference Number: WHO/BS/2017.2324
Copyright
World Health Organization CC BY-NC-SA 3.0 IGO